Cargando…

Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis

BACKGROUND: The treatment and prognosis of lung adenocarcinoma (LUAD) remains a challenge. The study aimed to conduct a systematic analysis of the predictive capacity of N6-methyladenosine (m6A)-related long non-coding RNAs (lncRNAs) in the prognosis of LUAD. METHODS: 594 samples were totally select...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Chen, Kong, Ning, Zhang, Fan, Zhou, Liuzhi, Xu, Maosheng, Wu, Linyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358839/ https://www.ncbi.nlm.nih.gov/pubmed/35941550 http://dx.doi.org/10.1186/s12859-022-04869-7

Ejemplares similares

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
por: Yalimaimaiti, Saiyidan, et al.
Publicado: (2023)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023)

A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature
por: Zhang, Ning, et al.
Publicado: (2023)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia
por: Zhang, Tong, et al.
Publicado: (2023)

A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
por: Di, Huang, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
por: Li, Qixuan, et al.
Publicado: (2023)

Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma
por: Wu, Qiong, et al.
Publicado: (2022)

Distinct tumor microenvironment landscapes in gastric cancer classified by cuproptosis-related lncRNAs
por: Huang, Jianfeng, et al.
Publicado: (2022)

Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
por: Gao, Chen, et al.
Publicado: (2022)

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer
por: Li, He, et al.
Publicado: (2022)

Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma
por: Zhang, Pei, et al.
Publicado: (2021)

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival
por: Cardillo, Nicholas, et al.
Publicado: (2021)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853
por: Chen, Leifeng, et al.
Publicado: (2023)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Liangping, et al.
Publicado: (2022)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
por: Chu, Binxiang, et al.
Publicado: (2022)

Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
por: Shi, Yinli, et al.
Publicado: (2023)

m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma
por: Pan, Junfan, et al.
Publicado: (2021)

Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Zhou, Jianghong, et al.
Publicado: (2023)

Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell
por: Sun, Yimeng, et al.
Publicado: (2023)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
por: Zhu, Hongfei, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
por: Liu, Chunhua, et al.
Publicado: (2023)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
por: Li, Mingyu, et al.
Publicado: (2023)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
por: Xu, Qi-Tong, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer
por: Wu, Lingfeng, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
por: Wu, Xiwen, et al.
Publicado: (2023)

5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma
por: Huang, Yinghui, et al.
Publicado: (2022)

m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma
por: Bi, Yikang, et al.
Publicado: (2022)

Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer
por: Peng, Yurui, et al.
Publicado: (2021)

The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma
por: Huang, Hanwen, et al.
Publicado: (2022)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer
por: Li, Ding, et al.
Publicado: (2022)

Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma
por: Zhang, Xiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_80hm9okmk9egsgpdo2d48alovi